United States · FDA National Drug Code directory
ProHance
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0270-1111_2124d0de-8f96-6f0d-6c42-7296def2661f
- Product NDC
- 0270-1111
- Form
- INJECTION, SOLUTION
- Composition / generic term
- gadoteridol
- Labeler
- BRACCO DIAGNOSTICS INC
- Marketing category
- NDA
- Marketing start / end (source format)
- 19921116
- Source listing expiry
- 20261231
Source-listed ingredients
- GADOTERIDOL — 279.3 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 5 VIAL, SINGLE-DOSE in 1 BOX (0270-1111-01) / 10 mL in 1 VIAL, SINGLE-DOSE · 0270-1111-01
- 5 VIAL, SINGLE-DOSE in 1 BOX (0270-1111-02) / 15 mL in 1 VIAL, SINGLE-DOSE · 0270-1111-02
- 5 VIAL, SINGLE-DOSE in 1 BOX (0270-1111-03) / 20 mL in 1 VIAL, SINGLE-DOSE · 0270-1111-03
- 5 VIAL, SINGLE-DOSE in 1 BOX (0270-1111-04) / 5 mL in 1 VIAL, SINGLE-DOSE · 0270-1111-04
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →